Andy Chevigné and his group, RTI-5152-twelve is postulated to increase the levels of opioid peptides that bind to classical opioid receptors within the brain, leading to heightened painkilling action. The LIH-RTI analysis teams established a collaboration arrangement and filed a joint patent application in December 2020.Conolidine CONOCB2™, that